title: Cancer, fertility and pregnancy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
authors.affiliation: Department of Medical Oncology, Ioannina University Hospital, Greece.
authors.forename: G
authors.initials: G
authors.lastname: Pentheroudakis
authors.forename: R
authors.initials: R
authors.lastname: Orecchia
authors.forename: H J
authors.initials: HJ
authors.lastname: Hoekstra
authors.forename: N
authors.initials: N
authors.lastname: Pavlidis
mesh_terms: D000932:Antiemetics / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000628:therapy; D003131:Combined Modality Therapy; D004358:Drug Therapy; D005060:Europe / Q000453:epidemiology; D005260:Female; D005298:Fertility / Q000187:drug effects*; D005500:Follow-Up Studies; D006801:Humans; D015994:Incidence; D007247:Infertility, Female / Q000139:chemically induced / Q000175:diagnosis / Q000628:therapy; D008545:Melanoma / Q000628:therapy; D009367:Neoplasm Staging; D009369:Neoplasms / Q000150:complications / Q000175:diagnosis / Q000628:therapy*; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic / Q000175:diagnosis / Q000628:therapy*; D011878:Radiotherapy; D018570:Risk Assessment; D012878:Skin Neoplasms / Q000628:therapy; D016896:Treatment Outcome; D002583:Uterine Cervical Neoplasms / Q000628:therapy
chemical_list: D000932:Antiemetics